The population frequency of patients with clinically ascertained and biochemically confirmed CBS deficiency varied considerably between countries, averaging ∼1 out of 1,500,000 inhabitants in Europe and yielding an estimated population frequency of pathogenic CBS alleles of 0.82 × 10−3. Here, CBS is linked to homocystinuria.